Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:29:14.537Z.
Calculation as of: 2026-10-06T21:29:14.537Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$47.98M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.72M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.71M
Operating Cash Flow Yield
11.68%
TTM Avg
4.34%
3Y Avg
2.96%
5Y Avg
2.96%
Market Cap
$48.76M
Operating Cash Flow Yield
N/A
TTM Avg
10.62%
3Y Avg
10.36%
5Y Avg
10.36%
Market Cap
$48.89M
Operating Cash Flow Yield
N/A
TTM Avg
4.17%
3Y Avg
3.77%
5Y Avg
3.39%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Instil Bio, Inc. (TIL) | $46.69M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 11.68% | 4.34% | 2.96% | 2.96% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A | 10.62% | 10.36% | 10.36% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A | N/A | N/A | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A | 4.17% | 3.77% | 3.39% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A | 1.36% | 0.72% | 0.95% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute